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Background: Streptococcus pyogenes is responsible for 5-15% and 20-30% of acute pharyngitis/tonsillitis in adults
and children, respectively. It not only causes acute illness but also can give rise to local suppurative complications
such as peritonsillar abscess as well as trigger the postinfectious syndromes of glomerulonephritis, acute rheumatic
fever and poststreptococcal reactive arthritis. Here, we report a case of a young healthy adult in whom both
peritonsillar abscess and poststreptococcal reactive arthritis developed as a complication of acute streptococcal
tonsillitis. To the best of our knowledge, such a coincidence of poststreptococcal sequelae has not been
reported previously.
Case presentation: A 32-year-old previously healthy woman was diagnosed with acute tonsillitis by her family
doctor and treated empirically with amoxicillin/clavulanic acid (875/125 mg) twice daily for 5 days. Four days after
completing antibiotic therapy, peritonsillar abscess of left tonsil developed. Needle aspiration followed by incision
and drainage were performed by otolaryngologist at the Emergency Department. Next, the patient was discharged
home on a 10-day course of cefuroxime and metronidazole. The symptoms of peritonsillar abscess were subsiding
during treatment, however on the last day of antibiotic therapy, swelling and pain of the left ankle appeared.
Five days later the patient was consulted by rheumatologist. Cultures of throat swabs and abscess aspirate
collected 2 weeks before revealed the presence of Streptococcus pyogenes. Antistreptolysin O (ASO) titer was
evaluated and proved to be 412 IU/ml (normal 0–200 IU/ml). The level of C-reactive protein was 13,0 mg/L
(normal <5,0 mg/L). There was no known cardiac involvement. Poststreptococcal reactive arthritis was diagnosed.
Left ankle arthralgia persisted for about 5–6 weeks. Six months after the presentation at the Emergency Department,
the patient was well, with ASO titer reaching 262 IU/ml.
Conclusions: Clinicians should be aware that appropriate choice of antibiotic, proper dose as well as duration of
therapy of acute GAS pharyngitis/tonsillitis are crucial to prevent poststreptococcal sequelae.
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Streptococcus pyogenes (group A streptococcus, GAS)
is responsible for 5 to 15% and 20 to 30% of acute
pharyngitis/tonsillitis in adults and children, respectively.
It not only causes acute illness but also can give rise to
local suppurative complications such as peritonsillar ab-
scess (PTA) as well as trigger the postinfectious syndromes
of glomerulonephritis, acute rheumatic fever (ARF) and
poststreptococcal reactive arthritis (PSRA) [1-3]. PTA, de-
fined as a collection of pus located between the tonsillar
capsule and the pharyngeal constrictor muscle, occurs
mainly in young adults [4,5]. PSRA is defined as arthritis
associated with proven streptococcal infection but not ful-
filling the modified Jones criteria for the diagnosis of acute
rheumatic fever [2,3]. Here, we report a case of a young
healthy adult in whom both, PTA and PSRA, developed as
a complication of acute streptococcal tonsillitis. To the
best of our knowledge, such a coincidence of poststrepto-
coccal sequelae has not been reported previously.
Case presentation
A 32-year-old woman was diagnosed with acute tonsil-
litis by her family doctor. Microbiological examination
was not performed at that time. Amoxicillin/clavulanic
acid 875/125 mg twice daily for 5 days was prescribed
empirically. The symptoms of tonsillitis resolved within
five-day treatment, however, four days after completing
the course of antibiotic therapy, sore throat, more promin-
ent on the left side, reappeared. Two days later the patient
presented to the Emergency Department with a two-day
history of worsening sore throat, painful swallowing and
fever. The patient was previously well, with no history of
chronic diseases, recurrent tonsillitis or previous periton-
sillar abscess. Seven months previously she gave birthTable 1 Summary of clinical findings and blood tests over tim
Timeline Clinical fin
Day 1: presentation to the family doctor Acute tons
Day 11: presentation to the Emergency Department Left side p
Day 20: 2nd presentation to the family doctor Left ankle
Day 25: follow-up visit to the Otolaryngology Department
and the rheumatologist consultation
Left ankle
Day 40: 1st follow up to the rheumatologist Left ankle
Day 100: 2nd follow up to the rheumatologist Healthy
Day 180: 3rd follow up to the rheumatologist Healthy
CRP: C-reactive protein; ASO: antistreptolysin titer.to her second child and was still breastfeeding the
baby. She denied smoking. On physical examination her
temperature was 38°C, pulse rate: 80 beats/min, re-
spiratory rate: 22 breaths/min and blood pressure: 120/
80 mm Hg. Examination of the oral cavity and oropharynx
showed enlarged and inflamed left tonsil as well as con-
gested and bulging soft palate on the left side with
contralateral displacement of the uvula. Both tonsils
were covered with whitish exudate. No dental caries was
noted. There was also bilateral, moderately tender sub-
mandibular lymphadenopathy. The remainder of physical
examination was unremarkable. Blood tests results are
shown in Table 1. Separate swabs were obtained from the
surfaces of both tonsils. Next, under local anesthesia, diag-
nostic needle aspiration of left tonsil was performed by
otolaryngologist, during which scanty amount of pus was
obtained. This initial procedure was followed by incision
and drainage. Tonsil swabs and abscess aspirate were sent
to laboratory for microbiological examination. The patient
refused hospitalization at the Otolaryngology Department,
thus was discharged home on a 10-day course of cefurox-
ime (500 mg twice daily) and metronidazole (500 mg 3
times daily) with recommendation to discontinue breast-
feeding for the duration of the antibiotic therapy and to
present at follow-up visit to Otolaryngology Clinic after
completing antibiotic therapy. The symptoms of periton-
sillar abscess as well as fever were subsiding steadily dur-
ing treatment, however on the last day of antibiotic
therapy, swelling and pain of the left ankle appeared, thus
the patient presented to her family doctor. Upon presenta-
tion she was afebrile and had marked oedema and pain of
her left ankle. Her heart rate was 72 beats/min, she did
not have an appreciable cardiac murmur. Her chest was
clear to auscultation. Antibiotic therapy with cefuroximee
dings Blood tests results
illitis Not performed
eritonsillar abscess Leukocytosis: 15 270/mm3 Granulocytes: 79.7%
Lymphocytes: 15.9%
Monocytes: 2.8%
Hemoglobin: 13.0 g/dl Hematocrit: 38.9%
Platelet count: 329 000/mm3
CRP: 131.0 mg/L (normal <5.0 mg/L)
arthritis Not performed
arthralgia ASO: 412 IU/ml (normal 0–200 IU/ml)
CRP: 13.0 mg/L
arthralgia ASO: 503 IU/ml
ASO: 396 IU/ml
ASO: 262 IU/ml
Mazur et al. BMC Infectious Diseases  (2015) 15:50 Page 3 of 5(500 mg once daily) for next 5 days was prescribed, as well
as pain relief medication with paracetamol. After complet-
ing antibiotic therapy the patient presented at follow-up
visit to Otolaryngology Clinic. She was afebrile, with nor-
mal vital signs. Examination of oropharynx showed reso-
lution of both, congestion and oedema of left tonsil and
soft palate. There was no exudate on the tonsils. Cultures
of throat swabs and abscess aspirate collected 2 weeks be-
fore revealed the presence of Streptococcus pyogenes in all
three materials. According to the patient report, left ankle
swelling with which she presented to her family doctor, re-
solved within 4 days. Upon presentation the patient only
had moderate pain in the joint. She was consulted by
rheumatologist. Her heart rate was 70 beats/min. She did
not have a regurgitant murmur. Her chest was clear to
auscultation. Antistreptolysin O (ASO) titer was evaluated
and proved to be 412 IU/ml (normal 0–200 IU/ml). The
level of C-reactive protein was 13,0 mg/L. Control throat
swabs were collected for culture, which revealed normal
oropharynx flora. The patient was recommended to con-
tinue pain relief medication with paracetamol and present
at follow-up visit to Rheumatology Clinic after 2 weeks.
Her only complaint was persisting slight pain in left ankle
joint. The results of physical examination were analogous
to those observed at previous follow-up. ASO titer was
503 IU/ml. Control throat swabs were collected and cul-
ture yielded normal flora. The patient was recommended
to present at follow-up visit at Rheumatology Clinic after
2 months. At that time, she was well. Ankle pain, accord-
ing to the patient report, disappeared shortly after last
visit. The results of physical examination were analogous
to those observed previously. ASO titer was 396 IU/ml.
Six months after the presentation at Emergency Depart-
ment, the patient was well, with ASO titer reaching
262 IU/ml. Table 1 summarizes the chronology of clinical
findings and blood tests results.
Bacteriology findings
Cultures of PTA aspirate revealed Streptococcus pyogenes
as a predominant species as well as Prevotella oralis and
Haemophilus parainfluenzae. Tonsil swabs, collected at
the time the patient presented with PTA, yielded copi-
ous growth of Streptococcus pyogenes as well as normal
throat flora, namely Streptococcus viridians, Neisseria spp,
and Haemophilus parainfluenzae. Two control throat
swabs revealed only normal oropharynx flora. Bacterial spe-
cies were identified with the use of routine microbiological
methods, drug susceptibility of S. pyogenes was assessed
using Vitek 2 Compact (bioMérieux). Antimicrobial suscep-
tibility results were interpreted according to the European
Committee on Antimicrobial Susceptibility Testing recom-
mendations (EUCAST 2013, version 3.1) [6]. Streptococcus
pyogenes strains isolated from tonsil swabs and abscess as-
pirate demonstrated identical susceptibility patterns. Theywere resistant to erythromycin, clindamycin, tetracycline
and fully susceptible to all other antibiotics tested. MLSi
phenotype (inducible coresistance to macrolide, lincosa-
mide and streptogramine) was detected with the use of
double-disc diffusion testing [7].
Discussion
GAS pharyngitis is a self-limiting disease in most cases,
however, it can cause suppurative and nonsuppurative
complications [1,2]. In our patient both, peritonsillar ab-
scess and poststreptococcal reactive arthritis occurred as
a complication of acute GAS tonsillitis. Although micro-
biological examination was not performed at the time
the patient presented with tonsillitis, the reappearance of
sore throat within 4 days after completing a 5-day anti-
biotic therapy with amoxicillin/clavulanic acid and the
presence of GAS in throat swab cultures at the time she
presented with PTA, strongly suggest GAS aetiology of
antecedent tonsillitis. Moreover, the isolation of GAS
strains with identical susceptibility patterns from both,
throat swabs and abscess aspirate, leaves no doubt that
GAS strain that caused tonsillitis participated in the de-
velopment of PTA. From the majority of PTA aspirates
polymicrobial mixture of aerobic and anaerobic bacteria
is recovered, however, GAS along with Fusobacterium
necrophorum are commonly regarded to be the primary
pathogens [4,5]. In our patient three bacterial species
were detected in abscess aspirate: GAS, Prevotella oralis,
and H. parainfluenzae. There are no uniform recom-
mendations regarding PTA antibiotic therapy, thus treat-
ment options vary greatly between clinicians and are
based mainly on their preferences [4,8,9]. In most cases
antibiotics of choice include penicillin combined with
metronidazole, amoxicillin with clavulanic acid, clinda-
mycin, cefuroxime, or metronidazole [8-10]. In our de-
partment cefuroxime combined with metronidazole is
administered as empiric antimicrobial therapy in most
cases, our patient was treated with these drugs as well.
PSRA is defined as arthritis associated with proven
streptococcal infection but not fulfilling the modified
Jones criteria for the diagnosis of acute rheumatic fever
(ARF). It is still not clear whether this entity represents
a distinct syndrome or is a manifestation of ARF [2,3].
ARF has now become rare in developed countries. Its in-
cidence in Western Europe is currently less than 1 case
per 100 000 population, whereas PSRA is relatively more
frequent with the annual incidence of approximately 2
cases per 100 000 people [11]. There is a mean interval
of 14 days between the onset of GAS pharyngitis symp-
toms and the occurrence of PSRA [3]. Age distribution
appears to be bimodal, with two incidence peaks, at ages
8–14 and 21–37 years, respectively [3]. Joint involve-
ment is typically non-migratory and affects large joints,
particularly those of lower limbs. Knee and ankle joints
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volvement occurs as well. Mono-, oligo- and polyarthri-
tis are equally represented. Unlike the self-limiting and
exquisitely responsive to salicylates arthritis of ARF,
PSRA responds relatively poorly to salicylates and non-
steroid anti-inflammatory drugs. Carditis is a rare event.
The disease resolves within weeks [3,11,12]. Discrimin-
ation between ARF and PSRA is ambiguous due to the
lack of generally accepted set of criteria for the diagnosis
of PSRA [11]. In our patient non-migratory monoarthri-
tis, localized in the left ankle, without fever or known
cardiac involvement occurred approximately 20 days
after the onset of tonsillitis while the patient was still on
antibiotic therapy due to PTA. Although joint oedema re-
solved within 4 days, arthralgia, moderately responsive to
nonsteroid anti-inflammatory drugs, persisted for about
5–6 weeks. Antecedent GAS throat infection was con-
firmed by cultures as well as serologically. However, the
modified Jones criteria were not fulfilled, thus PSRA was
diagnosed. Similarly to what was noted by Jansen et al.
[13], clinical findings of PSRA in our patient had subsided
before ASO titre reached its maximum value. At present,
there are no evidence-based guidelines whether patients
with PSRA, similarly to those with ARF, should receive
long-term antibiotic prophylaxis [11]. Recent data indicate
no increased risk of valvular heart disease in adults with
PSRA [14]. Accordingly, our patient did not receive sec-
ondary antibiotic prophylaxis.
Some European guidelines, among them British, Scottish,
Dutch and Belgian, consider GAS pharyngitis to be a
mild, self-limiting disease that does not require a spe-
cific diagnosis or antimicrobial treatment except in high-
risk patients, such as those with a history of valvular heart
disease or acute rheumatic fever, immunosuppressed or
severely ill [15-18]. Recently issued recommendations of
European Society of Clinical Microbiology and Infectious
Diseases represent similar approach [19]. However, the
remaining European and North American guidelines rec-
ommend that all cases of acute streptococcal pharyngitis/
tonsillitis should be appropriately treated to prevent both,
suppurative and nonsuppurative poststreptococcal com-
plications [20]. According to Polish recommendations,
phenoxymethyl penicillin, 2–3 million units twice daily for
10 days, is currently antibiotic therapy of choice for GAS
pharyngitis. Second and third-line drugs include: first gen-
eration cephalosporin in patients with penicillin allergy
who do not have immediate hypersensitivity to beta-
lactam antibiotics or macrolides (erythromycin, azithro-
mycin, clarithromycin) in those with hypersensitivity to
beta-lactam antibiotics. Azithromycin is the only drug
that is given in a 5-day course as opposed to a 10-day
course for all the other antibiotics [21]. Currently, American
Heart Association/American Academy of Pediatrics and
Infectious Diseases Society of America recommendamoxicillin once or twice daily for 10 days as alternative
first-line therapy, since in comparative clinical trials once-
daily amoxicillin (50 mg/kg, to a maximum of 1000 mg)
for 10 days has been shown to be effective for GAS pha-
ryngitis [2,22]. However, the treatment of tonsillitis in our
patient did not comply the recommendations, particularly
with respect to the duration of therapy. Five-day treatment
with amoxicillin/clavulanic acid resulted in the lack of
GAS eradication, which in turn caused both PTA and
PSRA.
Conclusion
In summary, to the best of the authors’ knowledge, this
is the first published account of the coincidence of both
PTA and PSRA, complicating acute GAS tonsillitis in a
young healthy adult. Moreover, the occurrence of both
complications might have an association with improper
management of acute streptococcal tonsillitis. Clinicians
should be aware that appropriate choice of antibiotic,
proper dose as well as duration of therapy of acute GAS
pharyngitis/tonsillitis are crucial to prevent poststrepto-
coccal sequelae.
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